- Home
- FDP vs KROS Comparison
FDP vs KROS Comparison
Compare FDP & KROS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FDP
- KROS
- Stock Information
- Founded
- FDP 1886
- KROS 2015
- Country
- FDP Cayman Islands
- KROS United States
- Employees
- FDP N/A
- KROS N/A
- Industry
- FDP Farming/Seeds/Milling
- KROS Biotechnology: Pharmaceutical Preparations
- Sector
- FDP Consumer Staples
- KROS Health Care
- Exchange
- FDP Nasdaq
- KROS Nasdaq
- Market Cap
- FDP 1.6B
- KROS 1.8B
- IPO Year
- FDP 1997
- KROS 2020
- Fundamental
- Price
- FDP $33.80
- KROS $55.92
- Analyst Decision
- FDP
- KROS Strong Buy
- Analyst Count
- FDP 0
- KROS 8
- Target Price
- FDP N/A
- KROS $91.43
- AVG Volume (30 Days)
- FDP 282.1K
- KROS 428.6K
- Earning Date
- FDP 10-31-2024
- KROS 11-06-2024
- Dividend Yield
- FDP 2.96%
- KROS N/A
- EPS Growth
- FDP N/A
- KROS N/A
- EPS
- FDP 0.32
- KROS N/A
- Revenue
- FDP $4,275,600,000.00
- KROS $651,000.00
- Revenue This Year
- FDP $0.65
- KROS $1,232.45
- Revenue Next Year
- FDP $2.55
- KROS $126.39
- P/E Ratio
- FDP $105.73
- KROS N/A
- Revenue Growth
- FDP N/A
- KROS 8037.50
- 52 Week Low
- FDP $21.23
- KROS $27.31
- 52 Week High
- FDP $35.27
- KROS $73.00
- Technical
- Relative Strength Index (RSI)
- FDP 65.76
- KROS 41.67
- Support Level
- FDP $33.30
- KROS $52.64
- Resistance Level
- FDP $34.02
- KROS $70.26
- Average True Range (ATR)
- FDP 0.70
- KROS 3.42
- MACD
- FDP -0.10
- KROS -1.21
- Stochastic Oscillator
- FDP 41.00
- KROS 18.64
About FDP Fresh Del Monte Produce Inc.
Fresh Del Monte Produce Inc is an integrated producer, marketer & distributor of fresh-cut fruit & vegetables. It operates in three segments, Fresh and value-added products segment, which includes pineapples, fresh-cut fruit, fresh-cut vegetables, melons, vegetables, non-tropical fruit, other fruit and vegetables, avocados, and prepared foods, Banana segment & Other products and services segment, including the third-party freight & logistic services business & the Jordanian poultry and meats business. The majority is from the Fresh and value-added products segment. Geographically, it operates in North America, Europe, Asia, the Middle East, and Other, out of which the highest is from North America.
About KROS Keros Therapeutics Inc.
Keros Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffering from hematological, pulmonary, and cardiovascular disorders with high unmet medical needs. The company's protein therapeutic product candidate, KER-050, is being developed for the treatment of low blood cells counts, or cytopenias, including anemia and thrombocytopenia, in patients with myelodysplastic syndromes, or MDS, and in patients with myelofibrosis.